Neuroprotective effects of MK-801 in different rat stroke models for permanent middle cerebral artery occlusion - Adverse effects of hypothalamic damage and strategies for its avoidance

被引:54
作者
Gerriets, T
Stolz, E
Walberer, M
Kaps, M
Bachmann, G
Fisher, M
机构
[1] Max Planck Inst Physiol & Clin Res, Kerckhoff Klin, Dept Radiol, Expt Neurol Res Grp, D-6350 Bad Nauheim, Germany
[2] Univ Giessen, Dept Neurol, Giessen, Germany
[3] Univ Massachusetts, Sch Med, Dept Neurol, Worcester, MA USA
关键词
animal models; cerebral infarction; MK-801; neuroprotection;
D O I
10.1161/01.STR.0000087171.34637.A9
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and Purpose-Permanent middle cerebral artery occlusion (MCAO) with the use of the suture technique causes hypothalamic damage with subsequent hyperthermia, which can confound neuroprotective drug studies. In the present study the neuroprotective effects of dizocilpine (MK-801) were compared in different permanent MCAO models with and without hypothalamic damage and hyperthermia. Methods-Sixty Sprague-Dawley rats were treated with MK-801 or placebo, beginning 15 minutes before MCAO, and assigned to the following groups: suture MCAO (group I), macrosphere MCAO without hypothalamic damage (group II), or macrosphere MCAO with intentionally induced hypothalamic infarction (group III). Body temperature was measured at 3, 6, and 24 hours. Lesion size was determined after 24 hours ( 2,3,5-triphenyltetrazolium chloride staining). Results-Hypothalamic damage was present in animals in group I and was intentionally induced in group III with the use of a modified macrosphere MCAO technique. Body temperature was significantly increased 3, 6, and 24 hours after MCAO in these 2 groups of animals. Hypothalamic damage and subsequent hyperthermia could be avoided effectively by limiting the number of macrospheres (group II). MK-801 provided a highly significant neuroprotective effect in group II but not in groups I and III. Conclusions-Hypothalamic damage with subsequent hyperthermia masked the neuroprotective effect of MK-801. This side effect can be avoided by using the macrosphere MCAO technique with a limited number of spheres. This model therefore may be more appropriate to study the effects of neuroprotective drugs in permanent focal cerebral ischemia than the suture method.
引用
收藏
页码:2234 / 2239
页数:6
相关论文
共 26 条
[1]   EFFECT OF MILD HYPERTHERMIA ON THE ISCHEMIC INFARCT VOLUME AFTER MIDDLE CEREBRAL-ARTERY OCCLUSION IN THE RAT [J].
CHEN, H ;
CHOPP, M ;
WELCH, KMA .
NEUROLOGY, 1991, 41 (07) :1133-1135
[2]   PROACT: A phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke [J].
del Zoppo, GJ ;
Higashida, RT ;
Furlan, AJ ;
Pessin, MS ;
Rowley, HA ;
Gent, M .
STROKE, 1998, 29 (01) :4-11
[3]   Recommendations for standards regarding preclinical neuroprotective and restorative drug development [J].
Feinklestein, SP ;
Fisher, M ;
Furland, AJ ;
Goldstein, LB ;
Gorelick, PB ;
Kaste, M ;
Lees, KR ;
Traystman, RJ ;
Albers, GW ;
Anwer, UE ;
Ashwood, T ;
Barone, FC ;
Basta, SL ;
Bogousslavsky, J ;
Buchan, AM ;
Cady, WJ ;
Chan, PH ;
Clemens, JA ;
Cox, BF ;
Craddock, RE ;
Cramer, SC ;
del Zoppo, GJ ;
Dielrich, WD ;
Elliott, P ;
Faden, AI ;
Feuerstein, GZ ;
Ginsberg, MD ;
Gold, M ;
Greene, WL ;
Hall, ED ;
Hsu, CY ;
Hunter, AJ ;
Lai, M ;
Lesko, LM ;
Levy, DE ;
Li, FH ;
Locke, KW ;
Lodge, D ;
Lowe, D ;
Marcoux, FW ;
McCulloch, J ;
McDermott, J ;
Meibach, R ;
Messersmith, EK ;
Moseley, M ;
Moskowitz, MA ;
Mueller, AL ;
Munro, F ;
Nudo, RJ ;
Oeda, J .
STROKE, 1999, 30 (12) :2752-2758
[4]   Intra-arterial prourokinase for acute ischemic stroke - The PROACT II study: A randomized controlled trial [J].
Furlan, A ;
Higashida, R ;
Wechsler, L ;
Gent, M ;
Rowley, H ;
Kase, C ;
Pessin, M ;
Ahuja, A ;
Callahan, F ;
Clark, WM ;
Silver, F ;
Rivera, F .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (21) :2003-2011
[5]   Neuroprotection, excitotoxicity and NMDA antagonists [J].
Gagliardi, RJ .
ARQUIVOS DE NEURO-PSIQUIATRIA, 2000, 58 (2B) :583-588
[6]   The macrosphere model - Evaluation of a new stroke model for permanent middle cerebral artery occlusion in rats [J].
Gerriets, T ;
Li, FH ;
Silva, MD ;
Meng, XJ ;
Brevard, M ;
Sotak, CH ;
Fisher, M .
JOURNAL OF NEUROSCIENCE METHODS, 2003, 122 (02) :201-211
[7]   DIAS I: Duplex-sonographic assessment of the cerebrovascular status in acute stroke - A useful tool for future stroke trials [J].
Gerriets, T ;
Postert, T ;
Goertler, M ;
Stolz, E ;
Schlachetzki, F ;
Sliwka, U ;
Seidel, G ;
Weber, S ;
Kaps, M .
STROKE, 2000, 31 (10) :2342-2345
[8]   Combating hyperthermia in acute stroke - A significant clinical concern [J].
Ginsberg, MD ;
Busto, R .
STROKE, 1998, 29 (02) :529-534
[9]   Why do neuroprotective drugs that are so promising in animals fail in the clinic? An industry perspective [J].
Green, AR .
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2002, 29 (11) :1030-1034
[10]   Effects of poststroke pyrexia on stroke outcome - A meta-analysis of studies in patients [J].
Hajat, C ;
Hajat, S ;
Sharma, P .
STROKE, 2000, 31 (02) :410-414